• Clinical Perspectives

    “Patient circumstances vary significantly with the type and severity of esophageal disease, pre-existing conditions, medications, attitudes and fears regarding treatments. Having spray cryotherapy as part of my practice greatly expands the available treatment options for patients.”

    “I find that busy patients who are leading active lives are attracted to spray cryotherapy as a treatment alternative because they feel it maximizes their chances of having a rapid and easy recovery.”

    “When Barrett’s esophagus progresses, treatments such as surgery, chemotherapy and radiation are considered. Even when these treatments are performed, there is still a significant risk of recurrence. Spray cryotherapy often gives me the ability to treat these patients and make a meaningful difference in their quality of life.”

    -Michael Smith, MD, MBA

    Medical Director, Temple Esophageal Program, Asst. Professor of Medicine, Temple University School of Medicine


    “Spray cryotherapy’s unique mechanism of action allows us to treat uneven tissue surfaces where contact-based techniques would not be effective.”

    -John Dumot, MD
    Medical Director, University Hospital, Ahuja Medical Center Digestive Health Institute


    “This is a paradigm shift; spray cryotherapy is an effective ablative procedure with straight forward dosimetry and a reasonable risk profile that allows you to treat early and get in front of problems.”

    -Gordon Downie, MD, PhD
    Clinical Professor at LSU, Shreveport


    “Spray cryotherapy is a very sophisticated and effective endoscopic procedure with a growing body of data to support its ability to produce a reliable and reproducible clinical result.”

    “We have experienced excellent outcomes with our patients when using spray cryotherapy. This is a very safe and effective endoscopic intervention – a technology that is here to stay.”

    “Spray cryotherapy is one of several different modalities that we use to treat dysplastic Barrett’s esophagus and early esophageal cancer. It is complementary to other endotherapy modalities, and is yet another endoscopic ablation option for our patients.”

    “I have not seen an endoscopic ablation technique that has as favorable a patient recovery profile as spray cryotherapy. In my experience, the post procedure recovery status is consistently excellent.”

    -Vivek Kaul, MD, FACG
    Associate Professor of Medicine & Acting Chief Div. of Gastroenterology & Hepatology, URMC/Strong Memorial Hospital